Curcumin suppresses proliferation of colon cancer cells by targeting CDK2

Area of Science:

• Phytochemistry
• Molecular Biology
• Cancer Research

Background:

• Curcumin, a phytochemical from turmeric, is recognized for its potential in cancer prevention.
• Existing research shows curcumin modulates various cellular signaling pathways and has multiple molecular targets in cancer cells.
• Identifying novel molecular targets is crucial for understanding curcumin's anti-cancer mechanisms.

Purpose of the Study:

• To identify a new molecular target of curcumin using computational and experimental approaches.
• To investigate the role of the identified target in curcumin-induced cell-cycle arrest and proliferation inhibition in colon cancer cells.

Main Methods:

• Shape screening and reverse docking were employed to identify potential curcumin molecular targets from the Protein Data Bank.
• In vitro and ex vivo kinase assays were performed to assess curcumin's effect on target kinase activity.
• Cell-cycle analysis (G1 arrest), Western blotting (protein expression and phosphorylation), and gene knockdown (sh-CDK2) were used to validate the target and mechanism in HCT116 colon cancer cells.

Main Results:

• Cyclin-dependent kinase 2 (CDK2) was identified as a potential molecular target of curcumin.
• Curcumin significantly suppressed CDK2 kinase activity, induced G1 cell-cycle arrest, and reduced retinoblastoma (Rb) phosphorylation in HCT116 cells.
• Knockdown of CDK2 in HCT116 cells mimicked curcumin's effects on cell-cycle arrest and proliferation, confirming CDK2 as a direct target.

Conclusions:

• Cyclin-dependent kinase 2 (CDK2) is identified as a direct molecular target of curcumin in colon cancer cells.
• Curcumin exerts its antiproliferative effects by inhibiting CDK2 activity, leading to G1 cell-cycle arrest.
• These findings provide a deeper understanding of curcumin's anti-cancer properties and suggest CDK2 as a key mediator.